By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Coming Soon
The SPRi biosensor is an innovative type of biosensor that is designed for use in a variety of applications, such as medical diagnostics, environmental monitoring, drug discovery, and food safety.
Using Surface Plasmon Resonance Imaging (SPRi) technology, the SPRi biosensor is able to detect minute changes in refractive index on a substrate surface, allowing detection of binding events between labelled molecules.
This technology has been used to detect a wide range of analytes, including proteins, DNA, and small molecules. Additionally, the SPRi biosensor can be used to measure the kinetic properties of biomolecular interactions, such as the association and dissociation rates.
The SPRi biosensor is a highly sensitive tool because it is able to detect changes in refractive index as small as 10-7 RIU. Furthermore, the system can measure binding interactions in real time, allowing for accurate and rapid measurements.
Additionally, the SPRi biosensor is highly specific, as it is able to distinguish between similar molecules due to its ability to measure the kinetic properties of the binding events.
The SPRi biosensor has been used for a variety of applications, including for the detection of foodborne pathogens, the identification of biomarkers, and the monitoring of drug-target interactions.
In addition, the SPRi biosensor can be used to evaluate the efficacy of drug delivery systems, as well as to study the binding dynamics of proteins and small molecules.
Overall, the SPRi biosensor is an invaluable tool for a variety of applications. Its high sensitivity and specificity make it ideal for medical diagnostics, environmental monitoring, drug discovery, and food safety.
Furthermore, its ability to measure kinetic properties of biomolecular interactions provides valuable insight into the binding dynamics of molecules.
The Global SPRi biosensor market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Biacore’s latest product is the Biacore T200, which is an automated SPRi system that can be used to analyze interactions between proteins, antibodies, DNA, and other molecules. The system utilizes surface plasmon resonance (SPRi) technology to measure binding events in real-time.
The system is designed to be used for a variety of applications, including drug discovery, protein-protein interaction (PPI) studies, and protein engineering.
The Biacore T200 uses a new SPRi technology that is faster and more sensitive than traditional SPRi systems, and is capable of detecting binding events with high specificity and sensitivity. The system is designed to be easy to use, with intuitive software and a graphical user interface.
It also has a built-in data analysis feature, which allows users to quickly analyze their data and identify binding events.
In addition to the Biacore T200, several other companies have released new SPRi products in the past few years. Pall Corporation, for example, has released two systems: the Pall SPRi SPR-3000 and the Pall SPRi SPR-5000. The SPR-3000 is a compact, automated SPRi system that utilizes the same technology as the Biacore T200.
The SPR-5000 is a large-scale system that uses a high-sensitivity detector to measure a wide range of interactions.The GE Healthcare Life Sciences SPRi system is another example of a new SPRi product.
The system is designed for both research and industrial applications, and is capable of analyzing a wide range of interactions. It also has a built-in data analysis feature, which can help users quickly analyze their data.
